Vital Signs - Strategies beyond BRIC: An Update on the African In Vitro Diagnostics Market

Regular Price: USD 450

Special Price USD 383

15% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 383

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on November 22, 2013, provides overview of global IVD market dynamics, discuss growth strategy, and explore early opportunities in the African IVD market.

Additionally, a company spotlight is provided for Global BioDiagnostics based in Temple, Texas. The company is focused on developing affordable diagnostic tests with the mission to improve global health and have developed a point-of-care diagnostic for tuberculosis.

Table of Contents

Vital Signs - Strategies beyond BRIC: An Update on the African In Vitro Diagnostics MarketVital Signs: November 22 2013This week's issue




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.